Anzeige
Mehr »
Mittwoch, 10.06.2026 - Börsentäglich über 12.000 News
Vier Bohrlöcher, vier Treffer - bestätigt sich hier ein neues Uran-System?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2AMFU | ISIN: FR0012202497 | Ticker-Symbol: DMS1
Frankfurt
10.06.26 | 17:52
1,360 Euro
+20,89 % +0,235
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
DIAGNOSTIC MEDICAL SYSTEMS SA Chart 1 Jahr
5-Tage-Chart
DIAGNOSTIC MEDICAL SYSTEMS SA 5-Tage-Chart
RealtimeGeldBriefZeit
1,3601,44020:30
Actusnews Wire
180 Leser
Artikel bewerten:
(1)

DMS GROUP OBTAINS MARKETING AUTHORIZATION FOR ITS NEW ONYX RADIOLOGY MOBILE

DMS GROUP OBTAINS MARKETING AUTHORIZATION FOR ITS NEW ONYX RADIOLOGY MOBILE

  • Obtaining certification under the European Medical Device Regulation (MDR)

  • Commercial launch of ONYX, a new generation of ultra-mobile and intelligent radiology mobile

  • First deliveries expected in Q3 2026

  • DMS Group strengthens its position in the global mobile radiology market

June 10, 2026 - 5:45 pm - Diagnostic Medical Systems (Euronext Growth Paris: FR0012202497 - ALDMS), a specialist in high-performance medical imaging systems for digital radiology and bone densitometry, is pleased to announce that it has obtained MDR (Medical Device Regulation) certification for its new ONYX mobile radiology system, paving the way for its commercialization on the European market.

This approval, issued under the new European Medical Device Regulation, now authorizes the marketing of ONYX on the European market and marks a structuring step in DMS Group's development strategy. First deliveries of equipment are expected in Q3 2026.

A NEW STEP IN DMS GROUP'S MOVE UPMARKET WITH A TECHNOLOGICAL PLATFORM AT THE SERVICE OF HOSPITAL MOBILITY

Designed to meet the growing mobility and flexibility needs of healthcare facilities, ONYX combines compactness, maneuverability, and advanced imaging performance. The system includes:

  • a next-generation X-ray tube based on carbon nanotube (CNT) technology, enabling miniaturization and significant reduction in system weight;
  • a "zero gravity" arm offering precise and effortless positioning;
  • an X-Tech Cell lithium-ion battery for extended battery life and ultra-fast charging;
  • the artificial intelligence features of the ADAM software, optimizing image quality and dose reduction.

With its compact design and high mobility, ONYX meets the operational requirements of the most demanding hospital environments, including intensive care, emergency or mobile units.

In addition to its clinical performance, ONYX is also an innovation with a strong economic impact for healthcare institutions thanks to:

  • Reduced maintenance costs;
  • Better operational continuity;
  • Extended life of critical components;
  • Workflow optimization.

Obtaining this MDR certification confirms DMS Group's ability to develop and industrialize innovative technological solutions that meet the most demanding regulatory standards.

It also illustrates the move upmarket of the Group's product portfolio and its ambition to position itself sustainably among the leading technological players in digital medical imaging.

DMS GROUP: A GROWTH DYNAMIC SUPPORTED BY INNOVATION

Winner of the 2024 Innovation Prize, awarded by the French Society of Radiology (SFR), ONYX illustrates DMS Group's innovation strategy and its ambition to offer differentiating solutions with high technological added value.

Its development is part of DMS Group's MC2 project, which aims to develop new high-end imaging solutions, manufactured in France. The MC2 project benefits from funding from the French government as part of the Recovery Plan for Industry - Strategic Sectors, and the Investments for the Future Program (PIA).

Beyond its own commercial networks, DMS Group also plans to offer ONYX to several industrial partners in white label collaborations, thus strengthening its positioning as a key player in the global medical imaging value chain.

With the commercial launch of ONYX, DMS Group is strengthening its radiology offering and supporting its international growth dynamic. The Group thus confirms its desire to accelerate the deployment of innovative solutions with high technological value in its strategic markets.

DMS Group confirms its strategy based on innovation, internationalization and the increase in value of its product offering. The Group intends to capitalize on the commercial launch of ONYX to accelerate its development in priority markets and continue to gradually improve its growth and profitability profile.

Samuel Sancerni, Chairman and Chief Executive Officer of DMS Group, comments:

"Obtaining MDR certification for ONYX is a major milestone for DMS Group. This launch is the culmination of several years of investment in R&D around a particularly innovative and differentiating platform. ONYX has strong technological and commercial assets that allow us to address a dynamic and buoyant global market.

With ONYX, we offer a new generation of equipment combining mobility, ergonomics, software intelligence and AI, fully meeting the new expectations of healthcare institutions. This new generation of mobile radiology is therefore an important lever for growth and value creation for the Group in the years to come."

UPCOMING EVENTS* :

  • 15/06/2026 General Assembly
  • 20/07/2026 Q2 2026 revenue
  • 28/09/2026 2026 half-year results

The publications will take place after the close of the Euronext market in Paris.
*Provisional schedule subject to change. Visit the DMS Group website.

Find financial information on our investor area: www.dms.com

Receive free financial information from DMS Group by registering on www.actusnews.com

ABOUT DMS GROUP
DMS Group is a French digital radiology manufacturer, internationally oriented, recognized as a key player and a key partner in the value chain, both for the quality of its solutions, and for its flexibility, ingenuity and responsible values.
In 2025, DMS Group achieved a consolidated revenue of €50 million, of which more than 75% was international, with a presence on all continents through a network of more than 140 national distributors.

DMS Group is listed on the Euronext Growth Paris market (ISIN: FR0012202497 - ticker: ALDMS) and is eligible for the PEA PME-ETI.
DMS Group is part of the ETIncelles program for SMEs that have the ambition and the desire to become mid-caps.

CONTACTS DMS GROUP

Investor Relations

relationinvestisseur@dms-imaging.com

Press Relations
relationpresse@dms-imaging.com
CONTACTS ACTUS
Mathieu OMNES

Investor and Analyst Relations
Tel.: +33 1 53 67 36 92
momnes@actus.fr
Fatou-Kiné N'DIAYE
Press Relations
Tel.: +33 1 53 67 36 34
fndiaye@actus.fr
------------------------
This publication embed "Actusnews SECURITY MASTER".
- SECURITY MASTER Key: lGhuacVpZGqUmW1sZ8iXb2RnapeSk2nHbmqclmeZmMjJmG+TxW+VapqWZnJpnGVp
- Check this key: https://www.security-master-key.com.
------------------------
Full and original release in PDF format:
https://www.actusnews.com/documents_communiques/ACTUS-0-98703-dms_cp_homologation-onyx_10062026_en.pdf

© Copyright Actusnews Wire
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
© 2026 Actusnews Wire
Software vor dem Comeback – diese 5 Aktien könnten durchstarten!
Während Halbleiter- und KI-Infrastrukturwerte von einem Hoch zum nächsten jagen, wurden viele Software-Aktien in den vergangenen Monaten regelrecht aus den Depots gedrängt. Die Angst vor Disruption hat Investoren zu einem radikalen Strategiewechsel veranlasst – mit der Folge, dass zahlreiche Qualitätsunternehmen heute auf Mehrjahrestiefs notieren.

Doch genau hier entsteht eine seltene Chance. Denn während die Bewertungen im Halbleitersektor inzwischen auf ambitionierten Niveaus liegen, ist der Bewertungsabschlag bei Software-Titeln so hoch wie seit Jahren nicht mehr. Gleichzeitig liefern viele Unternehmen weiterhin starke Wachstumszahlen und integrieren KI erfolgreich in ihre Geschäftsmodelle. Die Diskrepanz zwischen Kursentwicklung und operativer Stärke könnte sich schon bald auflösen.

Für Anleger bedeutet das: antizyklisch denken und gezielt zugreifen, bevor der Markt dreht. Denn erste technische Signale deuten darauf hin, dass sich die Trendwende bereits anbahnt.

In unserem aktuellen Spezialreport stellen wir fünf Software-Aktien vor, die besonders aussichtsreich positioniert sind – mit starker Marktstellung, attraktiver Bewertung und hohem Aufholpotenzial.

Jetzt den kostenlosen Report sichern – bevor der Software-Rebound Fahrt aufnimmt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.